SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-21-005674
Filing Date
2021-08-09
Accepted
2021-08-09 07:34:31
Documents
58
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcrx20210630_10q.htm   iXBRL 10-Q 1357942
2 EXHIBIT 10.3 ex_272063.htm EX-10.3 1726
3 EXHIBIT 10.4 ex_272109.htm EX-10.4 145321
4 EXHIBIT 10.5 ex_272110.htm EX-10.5 143845
5 EXHIBIT 10.6 ex_272111.htm EX-10.6 144131
6 EXHIBIT 31.1 ex_270086.htm EX-31.1 11677
7 EXHIBIT 31.2 ex_270087.htm EX-31.2 13853
8 EXHIBIT 32.1 ex_270088.htm EX-32.1 4545
9 EXHIBIT 32.2 ex_270089.htm EX-32.2 4341
15 exh103_01.jpg GRAPHIC 118552
16 exh103_02.jpg GRAPHIC 24138
17 exh104logo.jpg GRAPHIC 12376
  Complete submission text file 0001171843-21-005674.txt   7223229

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA bcrx-20210630.xsd EX-101.SCH 60291
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcrx-20210630_cal.xml EX-101.CAL 36861
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcrx-20210630_def.xml EX-101.DEF 427835
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcrx-20210630_lab.xml EX-101.LAB 407295
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcrx-20210630_pre.xml EX-101.PRE 440452
18 EXTRACTED XBRL INSTANCE DOCUMENT bcrx20210630_10q_htm.xml XML 1003280
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 211154642
SIC: 2836 Biological Products, (No Diagnostic Substances)